Literature DB >> 21073837

A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles.

J Chen1, D Hong, Z Wang, Y Yuan.   

Abstract

Neutral lipid storage disease with myopathy (NLSDM) is a type of lipid storage myopathy arising due to a mutation in the PNPLA2 gene encoding an adipose triglyceride lipase responsible for the degradation of intracellular triglycerides. Herein, we report the cases of two siblings manifesting slowly progressive proximal and distal limb weakness in adulthood. One of the patients had dilated cardiomyopathy, hearing loss and short stature. Muscle specimens of the 2 patients revealed muscular dystrophic features with massive lipid droplets and numerous rimmed vacuoles in the fibers. A novel homozygous mutation IVS2+1G > A in the PNPLA2 gene was identified in the 2 cases, but not in the healthy familial individuals. The presence of massive lipid droplets with muscular dystrophic changes and rimmed vacuoles in muscle fibers might be one of the characteristic pathological changes of NLSDM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073837     DOI: 10.5414/npp29351

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  8 in total

Review 1.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

2.  Symptomatic lipid storage in carriers for the PNPLA2 gene.

Authors:  Mirian C H Janssen; Baziel van Engelen; Livia Kapusta; Martin Lammens; Martin van Dijk; Judith Fischer; Marinette van der Graaf; Ron A Wevers; Manuela Fahrleitner; Robert Zimmermann; Eva Morava
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

3.  Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.

Authors:  Daniela Tavian; Sara Missaglia; Chiara Redaelli; Elena M Pennisi; Gloria Invernici; Ruediger Wessalowski; Robert Maiwald; Marcello Arca; Rosalind A Coleman
Journal:  Hum Mol Genet       Date:  2012-09-17       Impact factor: 6.150

4.  Neutral lipid storage disease with myopathy: A 10-year follow-up case report.

Authors:  Sara Missaglia; Daniela Tavian; Corrado Angelini
Journal:  Eur J Transl Myol       Date:  2022-06-17

5.  Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease.

Authors:  Franz Pw Radner; Susanne Grond; Guenter Haemmerle; Achim Lass; Rudolf Zechner
Journal:  Dermatoendocrinol       Date:  2011-04-01

Review 6.  Neutral Lipid Storage Diseases as Cellular Model to Study Lipid Droplet Function.

Authors:  Sara Missaglia; Rosalind A Coleman; Alvaro Mordente; Daniela Tavian
Journal:  Cells       Date:  2019-02-21       Impact factor: 6.600

Review 7.  Of mice and men: The physiological role of adipose triglyceride lipase (ATGL).

Authors:  Renate Schreiber; Hao Xie; Martina Schweiger
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-10-25       Impact factor: 4.698

8.  Neutral lipid storage disease with myopathy in China: a large multicentric cohort study.

Authors:  Wei Zhang; Bing Wen; Jun Lu; Yawen Zhao; Daojun Hong; Zhe Zhao; Cheng Zhang; Yuebei Luo; Xueliang Qi; Yingshuang Zhang; Xueqin Song; Yuying Zhao; Chongbo Zhao; Jing Hu; Huan Yang; Zhaoxia Wang; Chuanzhu Yan; Yun Yuan
Journal:  Orphanet J Rare Dis       Date:  2019-10-26       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.